- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02032472
Efficiency of Monitoring and Control Program of Hypertension Through Pharmacy Offices. APOF Project (APOF)
Efficiency Program Monitoring and Control of Hypertension Through Pharmacy Offices. APOF Project
Background: Hypertension in adults is the factor most prevalent cardiovascular risk and motivates further inquiries, generating a very high cost of medical care.
Objective: To evaluate the monitoring of well-controlled hypertensive patients Pharmacy Offices. Hypothesis: the monitoring of these patients through the Office of Pharmacy will be as effective in obtaining good control of blood pressure as it is to obtained through health centers. Design: Multicenter randomized controlled trial along one year of follow up. Location: the city of Cerdanyola del Vallès (Barcelona). Participants: All patients diagnosed with hypertension and good control criteria in the past year. Arms: Health centers (control) and Pharmacy Offices (intervention). Outcome variable: blood pressure under good control along the monitoring
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Barcelona
-
Cerdanyola del Valllés, Barcelona, Spain, 08290
- Institut Català de la Salut (ICS)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age not less than 18 years
- HTA controlled over 2 years of evolution
- Subjects with a history open to participating health centers or stable residence in the geographic area
- Subjects who agree to participate
Exclusion Criteria:
- Comorbidity and concomitant (Diabetes Mellitus, Heart failure or renal failure
- Patients with temporary residence in the geographic area of study
- Subjects of hypertension controlled by outside professionals to our primary care teams.
- Subjects with home care or any other cause which does not permit their displacement, transfer to the clinic or pharmacy during the evaluation period.
- Subjects with severe diseases of poor prognosis, hopefully less than one year of life.
- Subjects who do not have telephones.
- Subjects with communication problems (cognitive impairment, sensory, language barrier)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Health Center (usual practice)
Controlling arterial pressure in the health center (a common practice is carried out)
|
|
Experimental: Collaboration of pharmacies
Pharmacies cooperate in Measurement of Arterial Pressure of patients
|
Pharmacies cooperate in measuring blood pressure of patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of hypertensive patients with criteria for good control of their arterial pressure along one year follow up
Time Frame: Monitoring of patients for 12 months (from January 1 to December 31, 2010)
|
We considered as a for good control criterion , obtaining values of systolic arterial pressure to below 140 mm Hg and diastolic blood pressure below 90 mm Hg dea, held along the entire the year follow-up of patients
|
Monitoring of patients for 12 months (from January 1 to December 31, 2010)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
reduction in the number of visits to the health center to measure blood pressure
Time Frame: Monitoring of patients for 12 months (from January 1 to December 31, 2010)
|
The number of visits to the health center where blood pressure is measured.
We hope that the number of visits to the health center where blood pressure is measured is lower in the intervention group (the patients have the option to go to the pharmacy to carrying out checks blood pressure)
|
Monitoring of patients for 12 months (from January 1 to December 31, 2010)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Oscar Solans, G Physician, Institut Català de la Salut (Spain)
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- APOF_IDIAP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BayerCompletedPrimary HypertensionChina
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Addpharma Inc.Completed
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
Clinical Trials on Measurement of Arterial Pressure
-
Hopital FochCompleted
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Postgraduate Institute of Medical Education and...Recruiting
-
University Hospital, MontpellierCompleted
-
Institute of Liver and Biliary Sciences, IndiaCompleted
-
Hopital FochCompleted
-
I.M. Sechenov First Moscow State Medical UniversityCompletedRespiratory Failure | Pneumonia, Bacterial | COVID-19 PneumoniaRussian Federation
-
Bozyaka Training and Research HospitalCompletedSeptic Shock | Septicemia | Renal Injury | Intraabdominal HypertensionTurkey
-
University Hospital, AngersRecruiting
-
University Hospital, AngersNot yet recruiting